JACIE accreditation for blood and marrow transplantation: past, present and future directions of an international model for healthcare quality improvement
JACIE accreditation for blood and marrow transplantation: past, present and future directions of an international model for healthcare quality improvement
Blood and marrow transplantation (BMT) is a complex and evolving medical speciality that makes substantial demands on healthcare resources. To meet a professional responsibility to both patients and public health services, the European Society for Blood and Marrow Transplantation (EBMT) initiated and developed the Joint Accreditation Committee of the International Society for Cellular Therapy and EBMT-better known by the acronym, JACIE. Since its inception, JACIE has performed over 530 voluntary accreditation inspections (62% first time; 38% reaccreditation) in 25 countries, representing 40% of transplant centres in Europe. As well as widespread professional acceptance, JACIE has become incorporated into the regulatory framework for delivery of BMT and other haematopoietic cellular therapies in several countries. In recent years, JACIE has been validated using the EBMT registry as an effective means of quality improvement with a substantial positive impact on survival outcomes. Future directions include development of Europe-wide risk-adjusted outcome benchmarking through the EBMT registry and further extension beyond Europe, including goals to faciliate access for BMT programmes in in low- and middle-income economies (LMIEs) via a 'first-step' process.Bone Marrow Transplantation advance online publication, 27 March 2017; doi:10.1038/bmt.2017.54.
Journal Article
1367-1371
Snowden, J A
e61be132-15ba-465f-8cec-c547bed8c02c
McGrath, E
35a982dd-6d19-412b-9725-bd360f390ad4
Duarte, R F
0602fa6c-e8bf-4d11-97d1-9fd9401e3c80
Saccardi, R
88a829b7-7d35-4f83-b142-dde7f90aa532
Orchard, K.
794654ab-d6cc-488a-ac11-c9217433c7a2
Worel, N
9424f08a-9e6e-4bfb-a1f9-97b36b8f7cc3
Kuball, J
b5643f95-8e45-44b8-80c7-25d359921f0e
Chabannon, C
6243ea35-38e5-4c5b-b037-288d92edf595
Mohty, M
41c590bb-4dee-4b09-bd41-50c1ad49ebec
27 March 2017
Snowden, J A
e61be132-15ba-465f-8cec-c547bed8c02c
McGrath, E
35a982dd-6d19-412b-9725-bd360f390ad4
Duarte, R F
0602fa6c-e8bf-4d11-97d1-9fd9401e3c80
Saccardi, R
88a829b7-7d35-4f83-b142-dde7f90aa532
Orchard, K.
794654ab-d6cc-488a-ac11-c9217433c7a2
Worel, N
9424f08a-9e6e-4bfb-a1f9-97b36b8f7cc3
Kuball, J
b5643f95-8e45-44b8-80c7-25d359921f0e
Chabannon, C
6243ea35-38e5-4c5b-b037-288d92edf595
Mohty, M
41c590bb-4dee-4b09-bd41-50c1ad49ebec
Snowden, J A, McGrath, E, Duarte, R F, Saccardi, R, Orchard, K., Worel, N, Kuball, J, Chabannon, C and Mohty, M
(2017)
JACIE accreditation for blood and marrow transplantation: past, present and future directions of an international model for healthcare quality improvement.
Bone Marrow Transplantation, 52, .
(doi:10.1038/bmt.2017.54).
Abstract
Blood and marrow transplantation (BMT) is a complex and evolving medical speciality that makes substantial demands on healthcare resources. To meet a professional responsibility to both patients and public health services, the European Society for Blood and Marrow Transplantation (EBMT) initiated and developed the Joint Accreditation Committee of the International Society for Cellular Therapy and EBMT-better known by the acronym, JACIE. Since its inception, JACIE has performed over 530 voluntary accreditation inspections (62% first time; 38% reaccreditation) in 25 countries, representing 40% of transplant centres in Europe. As well as widespread professional acceptance, JACIE has become incorporated into the regulatory framework for delivery of BMT and other haematopoietic cellular therapies in several countries. In recent years, JACIE has been validated using the EBMT registry as an effective means of quality improvement with a substantial positive impact on survival outcomes. Future directions include development of Europe-wide risk-adjusted outcome benchmarking through the EBMT registry and further extension beyond Europe, including goals to faciliate access for BMT programmes in in low- and middle-income economies (LMIEs) via a 'first-step' process.Bone Marrow Transplantation advance online publication, 27 March 2017; doi:10.1038/bmt.2017.54.
This record has no associated files available for download.
More information
Accepted/In Press date: 13 February 2017
e-pub ahead of print date: 27 March 2017
Published date: 27 March 2017
Keywords:
Journal Article
Identifiers
Local EPrints ID: 413226
URI: http://eprints.soton.ac.uk/id/eprint/413226
ISSN: 0268-3369
PURE UUID: 230be51d-1e4c-4843-97e3-d8c12573da29
Catalogue record
Date deposited: 17 Aug 2017 16:30
Last modified: 16 Apr 2024 01:37
Export record
Altmetrics
Contributors
Author:
J A Snowden
Author:
E McGrath
Author:
R F Duarte
Author:
R Saccardi
Author:
K. Orchard
Author:
N Worel
Author:
J Kuball
Author:
C Chabannon
Author:
M Mohty
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics